Integra LifeSciences Holdings Corp. (IART)
12.01
-0.40
(-3.22%)
USD |
NASDAQ |
Jan 20, 16:00
12.03
+0.02
(+0.17%)
After-Hours: 20:00
Integra LifeSciences Holdings Cash from Investing (Quarterly): -15.59M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Clearpoint Neuro, Inc. | -0.199M |
| Tandem Diabetes Care, Inc. | 20.54M |
| iRhythm Holdings, Inc. | -89.20M |
| Perspective Therapeutics, Inc. | 13.99M |
| InfuSystem Holdings, Inc. | -0.252M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 40.91M |
| Cash from Financing (Quarterly) | -10.24M |
| Free Cash Flow | -14.47M |
| Free Cash Flow Per Share (Quarterly) | 0.3355 |
| Free Cash Flow to Equity (Quarterly) | 33.66M |
| Free Cash Flow to Firm (Quarterly) | 47.41M |
| Free Cash Flow Yield | -1.57% |